Equities

BrightPath Biotherapeutics Co Ltd

4594:TYO

BrightPath Biotherapeutics Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)47.00
  • Today's Change-1.00 / -2.08%
  • Shares traded165.90k
  • 1 Year change-58.77%
  • Beta1.2330
Data delayed at least 20 minutes, as of Nov 11 2024 01:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Directors & dealings data is unavailable for this security.

Directors & Officers

Click or tap a row for biographies

NameTitleCompensationAgeOfficer since
Kenichi NagaiPresident, Chief Executive Officer, Representative Director--492009
Yoichi TakeshitaChief Financial Officer, Director--532023
Norihiro NakamuraDirector of Drug Discovery Research, CSO, Director--552018
Akira YamadaDirector--662003
Hirotaka TakeuchiIndependent Director--772015
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.